理解，识别，计量和控制原料药中的杂质是必要的，因为新的分子实体处于临床开发阶段评估。
The understanding, identification, quantification and control of impurities in drug substances are essential as new molecular entities are evaluated in clinical development.
理解，识别，计量和控制原料药中的杂质是必要的，因为新的分子实体处于临床开发阶段评估。
The understanding, identification, quantification and control of impurities in drug substances are essential as new molecular entities are evaluated in clinical development.
应用推荐